Your browser doesn't support javascript.
loading
Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study.
Peled, Nir; Kian, Waleed; Inbar, Edna; Goldstein, Iris M; Zemel, Melanie; Rotem, Ofer; Rozenblum, Anna B; Nechushtan, Hovav; Dudnik, Elizabeth; Levin, Daniel; Zer, Alona; Keren-Rosenberg, Shoshana; Yust-Katz, Shlomit; Fuchs, Vered; Remilah, Areen A; Shelef, Ilan; Roisman, Laila C.
Afiliação
  • Peled N; Department of Oncology, The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Kian W; Department of Oncology, The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Inbar E; Department of Diagnostic Imaging, Rabin Medical Center, Davidoff Cancer Center, Petach Tikva, Israel.
  • Goldstein IM; Department of Oncology, The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Zemel M; Department of Oncology, The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Rotem O; Department of Oncology, Rabin Medical Center, Davidoff Cancer Center, Petach Tikva, Israel.
  • Rozenblum AB; Department of Oncology, Rabin Medical Center, Davidoff Cancer Center, Petach Tikva, Israel.
  • Nechushtan H; Department of oncology, Hadassah Medical Center, Jerusalem, Israel.
  • Dudnik E; Department of Oncology, Rabin Medical Center, Davidoff Cancer Center, Petach Tikva, Israel.
  • Levin D; Department of Diagnostic Imaging, The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Zer A; Department of Oncology, Rabin Medical Center, Davidoff Cancer Center, Petach Tikva, Israel.
  • Keren-Rosenberg S; Department of Oncology, Lin Medical Center, Haifa, Israel.
  • Yust-Katz S; Department of Oncology, Rabin Medical Center, Davidoff Cancer Center, Petach Tikva, Israel.
  • Fuchs V; Department of Oncology, The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Remilah AA; Department of Oncology, The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Shelef I; Department of Diagnostic Imaging, Diagnostic Imaging Institute, Soroka University Medical Center, Be'er-Sheba, Israel.
  • Roisman LC; Department of Oncology, The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
Neurooncol Adv ; 4(1): vdab188, 2022.
Article em En | MEDLINE | ID: mdl-35156036
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel